These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature. Gupta D; Zachariah A; Roppelt H; Patel AM; Gruber BL J Clin Rheumatol; 2008 Oct; 14(5):267-72. PubMed ID: 18679133 [TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort. Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C; Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950 [TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population. Avino LJ; Naylor SM; Roecker AM Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349 [TBL] [Abstract][Full Text] [Related]
6. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Awad M; Sierra CM; Mesghali E; Bahjri K J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970 [TBL] [Abstract][Full Text] [Related]
7. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers. Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958 [TBL] [Abstract][Full Text] [Related]
8. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population. McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985 [TBL] [Abstract][Full Text] [Related]
10. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. Urbancic KF; Pisasale D; Wight J; Trubiano JA Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892 [TBL] [Abstract][Full Text] [Related]
11. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia. Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456 [TBL] [Abstract][Full Text] [Related]
12. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era. Crewe-Brown HH; Reyneke MP; Khoosal M; Becker PJ; Karstaedt AS S Afr Med J; 2004 Jun; 94(6):440-2. PubMed ID: 15250455 [No Abstract] [Full Text] [Related]
13. Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors. Proudfoot R; Phillips B; Wilne S J Pediatr Hematol Oncol; 2017 Apr; 39(3):194-202. PubMed ID: 28267082 [TBL] [Abstract][Full Text] [Related]
14. [Reply to the authors. Infectious complications in lung transplantation for cystic fibrosis]. García-Morillo S; Respaldiza Salas N; Dapena Fernández FJ; de la Horra Padilla C Med Clin (Barc); 2006 Oct; 127(16):638. PubMed ID: 17183630 [No Abstract] [Full Text] [Related]
15. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628 [TBL] [Abstract][Full Text] [Related]
16. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients. Held M; Goebel FD Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444 [No Abstract] [Full Text] [Related]
17. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745 [TBL] [Abstract][Full Text] [Related]
18. Use of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia. Brun-Pascaud M; Fay M; Zhong M; Bauchet J; Dux-Guyot A; Pocidalo JJ Antimicrob Agents Chemother; 1992 Feb; 36(2):470-2. PubMed ID: 1605613 [TBL] [Abstract][Full Text] [Related]